Mechanism of Abnormal Coagulation Induced by Tigecycline in Cancer Patients

• Main Authors: Li-Hua Sun (Author), Kun-Hao Bai (Author), Guo-Yan Wu (Author), Xiao-Peng Tian (Author), Zhi-Qing Zou (Author), Da-Wei Wang (Author), Yu-Jun Dai (Author), Si-Liang Chen (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Tigecycline is a broad-spectrum active intravenous antibiotic that is active against methicillin-resistant staphylococcus aureus. In Phase 3 and 4 clinical trials, increased all-cause mortality was observed in patients treated with tigecycline compared to patients in the control group. The reason fo...